Compound ID | 1410
Synonym(s): R207910
Class: Diarylquinoline
| Details of activity: | Mycobacterium abscessus. Used to treat active tuberculosis |
| Institute where first reported: | Janssen Pharmaceutica, Belgium |
| Year first mentioned: | 2004 |
| Highest developmental phase: | Approved by FDA in 2012 |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5388906 |
| Guide to Pharmacology: | bedaquiline |
| Citation: | https://aac.asm.org/content/63/8/e00827-19 |